Sagimet Biosciences Announces Oral Presentation at the 9th Annual MASH-TAG 2025 Conference

SAN MATEO, Calif., Jan. 06, 2025 (GLOBE NEWSWIRE) — Sagimet Biosciences Inc. (Sagimet, Nasdaq: SGMT), a clinical-stage biopharmaceutical compan.

Continue

Do you trust this headline?

Based on recent headline ratings, 84% of this readership currently trusts the local media, which has an average score of 84% regionally and is currently trending positiveneutrally.

84%

Media Trust Score

Read All

In

News